- Home
- DFLIW vs HOWL Comparison
DFLIW vs HOWL Comparison
Compare DFLIW & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFLIW
- HOWL
- Stock Information
- Founded
- DFLIW N/A
- HOWL 2017
- Country
- DFLIW United States
- HOWL United States
- Employees
- DFLIW N/A
- HOWL 46
- Industry
- DFLIW Electronic Components
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- DFLIW Technology
- HOWL Health Care
- Exchange
- DFLIW Nasdaq
- HOWL Nasdaq
- Market Cap
- DFLIW N/A
- HOWL 38.0M
- IPO Year
- DFLIW 2021
- HOWL 2021
- Fundamental
- Price
- DFLIW $0.03
- HOWL $0.85
- Analyst Decision
- DFLIW
- HOWL Strong Buy
- Analyst Count
- DFLIW 0
- HOWL 3
- Target Price
- DFLIW N/A
- HOWL $9.00
- AVG Volume (30 Days)
- DFLIW N/A
- HOWL 262.3K
- Earning Date
- DFLIW N/A
- HOWL 05-06-2025
- Dividend Yield
- DFLIW N/A
- HOWL N/A
- EPS Growth
- DFLIW N/A
- HOWL N/A
- EPS
- DFLIW N/A
- HOWL N/A
- Revenue
- DFLIW N/A
- HOWL $1,885,000.00
- Revenue This Year
- DFLIW N/A
- HOWL N/A
- Revenue Next Year
- DFLIW N/A
- HOWL $733.33
- P/E Ratio
- DFLIW N/A
- HOWL N/A
- Revenue Growth
- DFLIW N/A
- HOWL N/A
- 52 Week Low
- DFLIW N/A
- HOWL $0.60
- 52 Week High
- DFLIW N/A
- HOWL $6.89
- Technical
- Relative Strength Index (RSI)
- DFLIW N/A
- HOWL 45.67
- Support Level
- DFLIW N/A
- HOWL $0.82
- Resistance Level
- DFLIW N/A
- HOWL $0.92
- Average True Range (ATR)
- DFLIW 0.00
- HOWL 0.10
- MACD
- DFLIW 0.00
- HOWL 0.03
- Stochastic Oscillator
- DFLIW 0.00
- HOWL 74.54
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.